Stemona alkaloids form a unique class, which can be attributed to hemiterpenoid pyrrolidine-and monoterpenoid pyrrolidine-class alkaloids originated from L-ornithine and glutamic acid. By the end of 2013, approximately 183 Stemona alkaloids had been isolated from nature. The literature on Stemona alkaloids in the realms of chemical structure, synthesis, and bioactivities has been elegantly summarized and reviewed. We thus summarize in this review the biosynthesis, structural classification, and the intrinsic, biogenetic relationships of Stemona alkaloids. Based on the comprehensive consideration of biogenetic pathways and chemical features, the 183 Stemona alkaloids are classified into two classes (hemiterpenoid pyrrolidine-and monoterpenoid pyrrolidine) and fourteen types.
Introduction
Stemona alkaloids, a class of structurally complex, polycyclic alkaloids, have been exclusively isolated from the Stemonaceae family consisting of 32 species of plants of three genera, Stemona, Croomia, and Stichoneuron. The largest of these is Stemona comprising about 25 species. The Stemonaceae are mainly distributed in Southeastern Asia, with some species extended to Australia [1, 2] . Most Stemona alkaloids have been obtained from Stemona species, with only a few being isolated from Croomia and Stichoneueron species. Most Stemona alkaloids are structurally characterized by a pyrrolo-[1,2-a]-azepine core (A), with a few exceptions that have either a pyrido-[1, 2-a]-or a pyrido-[1,3-a]azepine skeleton (B-1 or B-2). Sessilifoliamide J (1) [3] is the only representative that possesses an indolizidine nucleus (C), while sessilifoliamides K (2) and L (3) are the only two having a pyrido [1, 2-a]-azonine core (D) [4] . Most of the alkaloids contain one or two -methyl--lactone moieties (E) (Figure 1 ).
The classification of the Stemona alkaloids is extremely difficult due to their complicated structures. Based on the structural features of the pyrrolo-[1, 2-a]-azepine and pyrido-[1, 2-a]-azepine nuclei, Pilli and coworkers [5] [6] [7] classified the Stemona alkaloids into eight broad groups: stenine (I), stemoamide (II), tuberostemospironine (III), stemonamine (IV), tuberostemoamide (V), stemofoline (VI), stemocurtisine (VII), and miscellanerous ( Figure 2 ). Greger [8] systematically summarized the structural features of 82 alkaloids. On the basis of different carbon chains attached to the C-10 position of the pyrrolo-[1, 2-a]-azepine core (A), he then divided the Stemona alkaloids into three broad types: stichoneurine (I), protostemonine (II), and croomine (III) (Figure 3 ), and also illustrated the structural relationships between the different types of alkaloids. However, there was no illustration on the origin of the C 4 and C 8 in Figure 3 . Both Pilli's and Greger's classifications are heavily dependent on the structural features of pyrrolo-[1, 2-a]-or pyrido-[1, 2-a]-azepine systems. The classifications of many other alkaloids were typically based on the comprehensive considerations of biogenesis and chemical feature [9] [10] [11] [12] . The above-mentioned classifications of the Stemona alkaloids are consequently in need of improvement due to the fact that the biogenesis and the intrinsic, structural relationships have not yet been considered. For example, as the number of characterized alkaloids increases, it will be hard for the stemoamide-group, stemocurtisine-group, and miscellaneous group in Pilli's classification to remain as rational groups. The source or the chemical structure of each alkaloid has also been used as a criterion for classification of some alkaloids when its biogenesis or biosynthesis is unknown, which can be exemplified by Rauwolfia and quinoline alkaloids. Ideally, both biogenesis and chemical structure should be considered for a classification. A typical example is represented by the reclassification of quinine alkaloids, biogenetically derived from tryptophan, from quinolinetype [13] to monoterpenoid indole-class ( Figure 4 ) [13] [14] [15] . Approximately 183 Stemona alkaloids have been isolated from nature by the end of 2013. The literature on the Stemona alkaloids regarding chemical structure, synthesis, and bioactivities has been elegantly summarized and reviewed [5] [6] [7] [8] 16] . We thus summarize in this review the biosynthesis, structural classification, and the intrinsic biogenetic relationships of the Stemona alkaloids.
Biosynthesis
In addition to a discussion on the biogenetic relationships of different types of Stemona alkaloids [8] , there are merely three publications on biosynthetic investigations. In 2004, the Austrian scientists Seger and coworkers [17] first proposed a novel and constructive concept on the biosynthesis of Stemona alkaloids. The main contents include: (1) the relationships between the pyrrolo-[1, 2-a]-azepine skeleton and pyrrolidine-type alkaloids, together with monoterpenes; (2) three related building blocks: a C 3 NC 4 unit originated from spermidine (from putrescine), a C 10 -unit derived from geraninol, and a isoprene unit that is used to build the methyl--lactone side chain ( Figure 5 ); (3) amino acid precursors; and (4) the plausible mechanisms for cyclization and incorporation of the side chain (Scheme 1). The paper, however, has not received much attention. Five years later, Greger and co-workers [18] inferred the biosynthesis of the Stemona alkaloid croomine (Scheme 2) based on the fact that the proposed precursor pandanamine was indeed isolated from Stichoneuron calcicola. Figure 5 : The plausible building blocks for the Stemona alkaloids in Seger's biogenetic pathway [17] (*including the rearranged C 10 -geranyl unit).
Scheme 1:
Seger's biogenetic pathway for the Stemona alkaloids [17] .
Scheme 2:
Greger's biogenetic pathway for croomine [18] .  As shown in Scheme 3, a biogenetic pathway was proposed by Pyne and co-workers for the formation of Stemona alkaloids that contain a pyrido [1, 2-a]-azepine core [19, 20] . First, the precursor C that contains a piperidine ring was generated from the condensation of A, derived from 4 molecules of acetates, and 1,3-diaminopropane B. Its derivative D was then condensed with a geranyl unit to yield Stemona alkaloid E that has the pyrido [1,2a]-azepine core (Scheme [19, 20] .
This review illustrates and summarizes the plausible building blocks and pathways for the biosynthesis of Stemona alkaloids after comprehensively considering Seger's [17] biosynthetic theory.
Building Blocks
Dissection of a natural product into its basic building blocks is an essential and fundamental process to learn its biosynthetic pathway [11] . We propose the plausible building blocks ( Figure 6 ) for the Stemona alkaloids based on: i) the above-mentioned biogenetic pathways; ii) the structural characteristics of the 183 known Stemona alkaloids; and iii) the fundamental principles for biosynthesis [11, 14, 21] . Specifically, either the pyrrolo-or pyrido-[1, 2-a]-azepine nucleus, or the indolizidine core may consist of three building blocks: a pyrrolidine (A: I, II, III, IV) or piperidine (A': V) unit, a C 3 (B: I, III, V) or C 4 (B': II) unit, and either a C 2 (C: I, V) or C 1 unit (C': II, III) from the C 5 -isoprene or C 10 -geranyl units and their rearranged derivatives. Among them, the building block for IV is unique, as exemplified by sessilifoliamine A (4) [3] . In addition to the pyrrolidine moiety (A), the other five carbon atoms in the core structure may consist of a C 1 -unit derived from a C 5isoprene, a C 2 -unit from another C 5 -isoprene, and a C 2 -unit from malonyl-SCoA(B''). The pyrrolidine moiety in Figure 6 is apparently derived from L-ornithine, and the C 4 -unit may also come R' = C 5 (-methyl--lactone)-, C 4 -, C 3 -, C 1 -units A: L-ornithine, A': derived from 4-C 4 unit-containing pyrrolidines, B: C 3 unit, B': C 4 unit, B'': C 2 unit, C: either C 5 -isoprene or C 10 -geranyl unit and their rearranged derivatives from L-ornithine. The piperidine ring may originate from either the ring expansion of pyrrolidine [8] or the participation of 4--methyl--lactone [4] . The C 3 -unit may be derived from either glutamic acid or 2-oxoglutaric acid, both of which could be interchangeable (Scheme 4) [11] . The side chain (R') at C-4 could be regarded as a substituent group. In most cases, it may be derived from the methyl--lactone moiety of the C 5 -isoprene. A few of them consist of either a C 4 -or a C 3 -unit. Methylstemofoline (5) [22] is the only compound that has a CH 3 group (C 1 -unit) as the R' side chain. In addition to those having a lactam moiety, there are 14 alkaloids possessing H in the place of the side chain. It is apparent that the C 5 -isoprene unit and its rearranged derivative originate from either IPP or DMAP (Scheme 5) and that the C 10 -monoterpene moiety is derived from naturally abundant trans-geraniol   and its rearranged derivatives (Scheme 5).
Construction mechanisms for the pyrrolo-and pyrido-[1, 2a]-azepine skeletons and the indolizidine core
Chemical principles and reaction mechanisms are fundamental tools for illustrating a biosynthetic process, which can be used to not only explore the biosynthetic pathways for natural products but also unveil the intrinsic relationships between the different molecules  . The biosynthetic pathways of the Stemona alkaloids are summarized below, starting from the above-mentioned building blocks. 
L-Ornithine + Glutamic acid + Hemi-/mono-terpene pathway
As illustrated in Scheme 6, bond C(1)-C(10) (a) may be first formed via the nucleophilic addition of hemi-/mono-terpene (a, c) or its rearranged derivative (b, d). The biosynthesis of alkaloids A-D can then be completed by the subsequent build-up of bond C(8)-C(9) (b) via an aldol reaction and formation of Schiff base (c). Stemoamide (6) [24] , parvineostemonine (7) [25] , neostemocochinine (8) [26] , and sessilifoliamide D (9) [27] are representative examples that may be biosynthesized through this pathway. There is no statement in Seger's biosynthetic pathway [17] regarding the formation of bond C(8)-C(9) from aldehyde (A) and B (Scheme 1), which is hard to explain using a nucleophilic addition reaction. About 60% of Stemona alkaloids possess an oxygenated substituent at either C-9 (Schemes, 6, 7) or C-10 (Schemes 8, 9) , confirming that bond C(8)-C(9) or C(9)-C(10) are formed through aldol reaction. As shown in Wang & Chen Scheme 7, the only difference for the biosynthesis of the indolizidine-containing Stemona alkaloids, as exemplified by sessilifoliamide J (1) [3] , is that a C 1 -unit from a hemiterpene moiety participates in the construction of the six-membered piperidine. Specifically, alkaloid B could be formed through a three-step sequence including the formation of Schiff base (a) and generation of A via an aldol reaction (b), followed by nucleophilic addition (c) (Scheme 7). a: hemiterpenes, b: rearranged hemiterpenes, c: monoterpenes, d: rearranged mono-terpenes; A: hemiterpenoid pyrrolidines, B: rearranged hemiterpenoid pyrrolidines, C: monoterpenoid pyrrolidines, D: rearranged monoterpenoid pyrrolidines.
Scheme 6: L-ornithine + glutamic acid +hemi-/mono-terpene biosynthetic pathway
Scheme 7: L-Ornithine + glutamic acid + hemiterpene biosynthetic pathway.
2 x L-Ornithine + Hemi-/ Mono-terpene pathway
As illustrated in Scheme 8, this biosynthetic pathway is similar to the one shown in Scheme 7 with the only difference being the substitution of glutamic acid with L-ornithine, which is exemplified by tuberostemospironine (10) [24] . The fact that, so far, no isolated naturally occurring monoterpenoid pyrrolidine alkaloid has been biogenetically synthesized by the pathway described in Scheme 8 cannot exclude the possibility of its existence. Scheme 8: 2 x L-Ornthine + hemiterpene biosynthetic pathway.
L-Ornithine + 2 x Hemiterpene + Malonyl-SCoA pathway
Sessilifoliamine A (4) [3] is the only compound known to be biosynthesized through this pathway. Its plausible biosynthetic processes, as shown in Scheme 9, are characterized by the collective assembly of the pyrrolo-[1, 2-a]-azepine skeleton by a pyrrolidine moiety formed from L-ornithine, a carbon atom derived from a C 5isoprene unit, two carbon atoms originating from another C 5isoprene unit, and a C 2 -unit from a malonyl-SCoA unit. There are about 16 alkaloids possessing a pyrido-[1, 2-a]-azepine core. Nine of them contain a rearranged skeleton that was transformed from the pyrrolo-[1, 2-a]-azepine core through a Wagner-Meerwein-type ring condensed-ring expansion rearrangement. The other seven alkaloids might be derived from ring expansion participated by the C 4 -carbon chains at C-4 [28] . Greger and Hofer et al. [8, 28] proposed a plausible mechanism: decarboxylation of the 4--methyl--lactone moiety in the precursors (A) generated the intermediate aziridine (B), and the bond cleavage between N-C(4), followed by the subsequent ring expansion, provided the alkaloids (C) that possess a pyrido-[1, 2-a]azepine core (Scheme 10). In addition, stemocurtisine (11) [29] and stemocurtisine N-oxide (12) [30] are the only two alkaloids that have a pyrido-[1, 2-a]-azepine skeleton, but without a C-4 side chain. They might be biogenetically derived from the degradation of their precursor alkaloids with a C-4 side chain. 
Introduction of the -methyl--lactone units
As mentioned previously, the -methyl--lactone unit at C-4 in the Stemona alkaloids should be derived from the C 5 -isoprene unit of either IPP or DMAP with its plausible incorporation mechanism as described in Scheme 11. Specifically, the intermediate A could be
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Natural Product Communications Vol. 9 (12) 2014 1813 generated by allylic oxidation of either IPP or DMAP, followed by a three-step transformation including S N 1 reaction, allylic rearrangement [11] , and proton transfer. The intermediate C could then be formed by aza-Prins reaction of the imminium ion (B) derived from the pyrrolo-[1,2-a]-azepine or indolizidine core with the intermediate A. The alkaloid E could eventually be achieved by a 1,2-H shift of the intermediate C followed by hydroxylation and dehydration (Scheme 11).
Incorporation of C 4 carbon chains
The C 4 -carbon chain at C-4 in the Stemona alkaloids (B) could be introduced by decarboxylation of -methyl--lactone in the alkaloids (A) (Scheme 12) [8, 28, 31 ].
Incorporation of C 3 -and C 1 -carbon chains
Only those alkaloids that contain a pyrido-[1, 2-a]-azepine core possess a C 3 -unit side chain. Its plausible biosynthetic mechanism is illustrated in Scheme 10. Methylstemofoline (5) [22] represents the only example that has a CH 3 substituent group at C-4. The 4-CH 3 might be introduced by the degradation of the  2'(3') bond of its precursors (A), as exemplified by didehydrostemofoline (13) [31] (Scheme 13).
Classifications
The above-discussed biosynthetic pathways suggested that the Stemona alkaloids could be regarded as hemiterpenoid/ monoterpenoid pyrrolidine alkaloids biogenetically derived from Lornithine and glutamic acid. We thus classified the Stemona alkaloids into two classes: hemiterpenoid pyrrolidine (A) and monoterpenoid pyrrolidine (B) (Figure 7 ). Each class is sub-divided into different types based on the different skeletons and structural feature of each alkaloid. Based on these criteria, the Stemona alkaloids can be classified into two classes and fourteen types. core or at C-1 in those having a pyrido-[1, 2-a]-azepine skeleton is also systematically numbered, using the nomenclature criteria of those isoprenyl-containing natural products, such as flavonoids and lignans.
Hemiterpenoid pyrrolidine-class alkaloids 3.1.1. Stemoamide-type
This type contains six alkaloids: stemoamide (6), stemonine (14), parvistemoamide (15) , stemocochinnamine (16) , oxystemokerrilactone (17) , and parvineostemonine (7) ( Table 1) . Parvineostemonine (7, Table 1 ) also represents the only example that has a rearranged hemiterpene moiety and an extremely uncommon C(11)-C(1') bond.
As previously described, the pyrido-[1, 2-a]-azepine skeleton in the alkaloids 16-17 is biogenetically originated from the pyrrolo [1,2-a] azepine coresthat contain the -methyl--lactone moiety.
Croomine-type
There are sixteen alkaloids of this type (10, 18-31, 1, Table 1 ), featuring a spiro-moiety in their structures.
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Wang & Chen Sessilifoliamide J (1) is the only Stemona alkaloid with the combination of an indolizidine core and a spiro-moiety.
It is logical for Greger [8] to classify the stemoamide-type alkaloids into the protostemonine-type. However, this cannot exclude the existence of a 2X L-ornithine-hemiterpene pathway for the hemiterpenoid pyrrolidine-class alkaloids, which can be forcefully corroborated by the presence of the croomine-type alkaloids.
Sessilifoliamine A-type
As mentioned above, this is a unique type of hemiterpenoid pyrrolidine class with sessilifoliamine A (4, Table 1 ) as the only example. It is essential to list this compound as an individual type because of its exceptional biosynthetic pathway, as shown in Scheme 9, and its unprecedented structure. S. tuberosa [24, 40] S. tuberosa [41] S. japonica [24, 40] Croomia heterosepala [42] C. japonica [43] Stemona japonica [43] S. tuberosa [40, 44] Stichoneuron caudatum [45] Stemospironine ( S. japonica [32] S. sessilifolia [35] S. tuberosa [40] S. tuberosa [40, 44, 45] Dehydrocroomine ( 
Monoterpenoid pyrrolidine-class alkaloids

Protostemonine-type
There are 21 known protostemonine-type alkaloids (32-51) ( Table  2) , of which 8 and 36-51 structurally feature an additional 9,12epoxy moiety. Due to their relatively simple structures, they may serve as important biogenetic precursors for other complex monoterpenoid pyrrolidine-class alkaloids.
Stemona alkaloids
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Stemonamine-type
This type contains nine alkaloids (52-60, Table 2 ), structurally featuring a spiro ring and an -methyl--unsaturated fivemembered cyclic ketone. Most of them lack an oxygenated substituent at C-9, with oxymaistemonine (57) as an only exception.
Stemofoline-type
This type, consisting of twenty-one alkaloids (5, 13, 61-79, Table  2 ), is structurally more complex and constitutes the major portion of the monoterpenoid pyrrolidine-class alkaloids. The cage-shaped pyrrolo-[1, 2-a]-azepine moiety renders their unique structures. In addition, their structures are distinguished from most other Stemona alkaloids in having either a C 4 -or C 1 -unit side chain instead of an -methyl-lactone unit or its derivative at C-4.
As illustrated in their structures, parvistemoninine (78) and parvistemoninol (79) are the isomers of the above-mentioned stemofoline-type alkaloids, only differing in the configurations at C-2, C-4, C-8, C-9, C-10, and C-11.
Greger and co-workers [31] proposed that the stemofoline-type alkaloids were derived biogenetically from protostemonine (45), but without providing the corresponding biosynthetic mechanism. We thus analyze its putative biosynthetic process in Scheme 14 using 16-hydroxystemofoline (74) as an example.
Scheme 14:
Plausible biosynthetic mechanism for the stemofoline-type alkaloids.
Stemocurtisine-type
This type consists of nine alkaloids (11, 12, 80-86, Table 2 ). 6-Hydroxy-5,6-seco-stemocurtisine (86) is the only representative with the N-C(6) bond cleaved.
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Cochinchistemonine-type
Cochinchistemonine (87) and cochinchistemoninone (88) ( Table 2) represent the only two examples of this type.
Similar to stemocochinamine (16) and oxystemokerrilactone (17), stemocurtisine-and cochinchistemonine-type alkaloids are also grouped into the monoterpenoid pyrrolidine-class alkaloids.
Scheme 15 illustrates the plausible biogenetic relationships between different types of alkaloids within the monoterpenoid pyrrolidineclass, based on the above-mentioned criteria in combination with the information described in the literature [8, 28, 31, 52] . 
Stichoneurine-type
This type contains five alkaloids: sessilifoliamides D (9), B (89), and C (90), as well as stichoneunines A (91) and B (92) ( Table 2 ).
Stemona-amine C-type
Stemona-amines C (93) and D (94) ( Table 2 ) are the only two known compounds belonging to this type.
Tuberostemoamide-type
As a large group containing twenty-two known alkaloids (95-116, Table 2 ), their structures feature the participation of a monoterpene moiety in the formation of both the pyrrolo-[1, 2-a]-azepine skeleton and the spiro moiety or the tetrahydrofuran fused with the -methyl--lactone unit.
Stemona alkaloids
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Stenine-type
As the largest type of Stemona alkaloids with thirty-nine naturally occurring alkaloids, none of which have an oxygenated substituent at C-9 (117-156, Table 2 ). Intriguingly, stemoxazolidinones D-F (138-140) and stemona-amine F (152) contain a carbamoyl group, while stemona-amine E (151) has an extra two-carbon unit at C-2
It is worthy of note that stenine B (119) and sessilifoline B (118) [54] were reported as having the same structure, but their spectral data are not identical. Thus, it is very possible that the structure of sessilifoline B is wrong because the structure of stenine B has been confirmed by chemical correlation with X-ray analysis of its derivative [53] . The plausible biogenetic mechanism of oxotuberostemonine (155) was described in the literature [55, 56] .
seco-Stenine-type
Alkaloids 156-166 (Table 2 ) might be biogenetically generated from the stenine-type alkaloids. For example, cleavage of either the C(1)-C(2) or C(1)-C(10) bond in tuberostemonoxirine (135) may lead to the formation of this type of alkaloids.
Wang & Chen
Scheme 16
The carbonyl group at C-1 might show the larger character of ketone due to the bridgehead location of the nitrogen atom. Consequently, the rearranged stenine-type (B) or stenine-type (C) alkaloids could be biogenetically formed through the construction of the C(2)-C(10) bond (a) or the C(1)-C(14) bond (b) via aldol reaction (Scheme 16).
Rearranged stenine-type
This type contains nineteen alkaloids (167-183, 2, 3) , Table 2 ), which, except for sessilifoliamides K and L, could be biogenetically derived from the stenine-type alkaloids via either a 1,2-shift or a successive 1,2-shift. It is worth noting that stemoxazolidinones A (172), B (173), and C (174) contain a carbamoyl group.
The piperidine ring-containing alkaloids (175-183) are biosynthetically derived from the stenine-type alkaloids (A) rather than L-lysine through a sequential procedure including Wagner-Meerwein (W. M.) rearrangement, hydroxylation, and oxidation (Scheme 17). Alternatively, it could also be formed from secostenine-type alkaloids (Scheme 16). The 2-hydroxyl-containing rearranged stenine-type alkaloids (D), such as neotuberostemoninol (178), could be converted to seco-stenine-type alkaloids (E) via retroaldol reaction (Scheme 17).
Scheme 17
The biogenetic pathway of tuberostemoenone (170) in the literature [55] is not accurate; very possible, it is biogenetically synthesized from 1,9-epoxy-9a-hydroxystenine (125) through the process shown in Scheme 18.
Scheme 18
Scheme 19
Scheme 20: Biogenetic relationships between the monoterpenoid pyrrolidine-class alkaloids Sessilifoliamides K (2) and L (3) are the only examples that have a pyrido [1,2-a] azonine core. They are biogenetically derived from S. tuberosa [41] S. tuberosa [84] S. sessilifolia [54, 56] S. tuberosa [16, 24, 31, 47, 65] Stichoneuron caudatum [ * 2'-Hydroxystemofoline may be the same as (2'S)-hydroxystemofline (67) based on its [] D and NMR data [22, 65] .
the rearranged stenine-type alkaloids (A) through hydrolysis and reformation of a lactam moiety, resulting in participation of the entire -methyl--lactone unit of A in the assembly of piperidine (Scheme 19) [4] . Indeed, the piperidine ring is not biogenetically derived from L-lysine. Consequently, they are also regarded as part of the monoterpenoid pyrrolidine-class.
Collectively, the monoterpenoid pyrrolidine-class is the largest (around 95 alkaloids in total) and most complex class of Stemona alkaloids. In reference to the reported information in the literature [8, 28, 53, 55, 56] , the biogenetic relationships between different types, in addition to those shown in Scheme 15, are summarized in Scheme 20. For clarification, the C-4 side chains are ignored in this scheme. Based on the relationships illustrated in Scheme 20, the stichoneurine-type alkaloids with the simpler and more primitive structures are the critical, biogenetic precursors for other types of alkaloids. There are two plausible ways to transform the stichoneurine-type alkaloids to other types of alkaloids: formation and rearrangement of either a C-C bond or a C-O bond. The former involves a common key reaction, such as aldol reaction, nucleophilic addition, and Michael addition; while the latter involves, for example, Wagner-Meerwein rearrangement.
Formation of a new bond may lead to a more complicated structure due to secondary cyclization. Rearrangement can result in simultaneous ring condensing and expansion, accompanied by structural conversion to different types.
Conclusion
The biosynthesis of the Stemona alkaloids is unique because: i) unlike pyrrolidine alkaloids (only ornithine is involved in their biosynthesis), the Stemona alkaloids involve two amino acids, Lornithine and glutamic acid, in their biosynthetic processes; ii) monoterpenes and their rearranged derivatives rather than the secologanin in monoterpene indole alkaloids are involved in the biosynthetic processes; and iii) hemiterpenes and their rearranged derivatives are involved in the processes. In addition to the biosynthesis of ergot alkaloids, it is rare for a hemiterpene to participate in a biosynthetic process. All these fully reflect the diversity of their building blocks, complication of their biosynthetic pathways, and the complexity of their structural types. Therefore, the Stemona alkaloids are a class of unique alkaloids, which can be attributed to hemi-and mono-terpenoid pyrrolidine-class alkaloids originating from L-orithine and glutamic acid, and clearly classified into two classes: hemiterpenoid pyrrolidine-and monoterpenoid pyrrolidine and 14 types.
